Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

EVONIK INDUSTRIES AG

(EVK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Virtual Global Chemicals Conference, Boston (Morgan Stanley)

11/11/2021 | 07:07am EST

Evonik

Leading Beyond Chemistry

Company Presentation Q3 2021

Key messages Q3 2021

FCF outlook raised to ~€1 bn - Set for structural growth in FY 2022

Q3 with adj. EBITDA of €645 m continuing on strong Q2 level … despite ~€30 m negative temporary & one-time effects

Price increases gaining track: Q3 at +8% in growth divisions (Q2: +2%)

Cost inflation managed well and compensated by price increases already in Q3

Sustained positive trends into Q4 - FY adj. EBITDA outlook specified to ~€2.4 bn (top end of previous range)

Record strong FCF of €937 m in 1-92021 - FY FCF outlook raised to ~€1 bn

Growth drivers in place & cost inflation under control - Set for continued structural growth in FY 2022

2 | November / December 2021 | Evonik Q3 2021 Company Presentation

Table of contents

  1. Evonik at a glance
  2. Strategy
  3. Financials Q3 2021
  4. Appendix

3 | November / December 2021 | Evonik Q3 2021 Company Presentation

LEADING BEYOND CHEMISTRY

TO IMPROVE LIFE, TODAY AND TOMORROW

4 | November / December 2021 | Evonik Q3 2021 Company Presentation

Leading Beyond Chemistry - Our purpose

Evonik on the way to become a best-in-class specialty chemicals company

Leading …

… Beyond …

… Chemistry

  • Leading market positions in 80% of our business
  • Leading key financial indicators
  • Connecting skills and perspectives
  • Develop solutions together with partners
  • Sustainability key driver of growth
  • Clear focus on specialty chemicals
  • Target 100% specialty portfolio

5 | November / December 2021 | Evonik Q3 2021 Company Presentation

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

Evonik Industries AG published this content on 11 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 November 2021 12:06:05 UTC.


ę Publicnow 2021
All news about EVONIK INDUSTRIES AG
01/20EVONIK : JP Morgan reiterates its Buy rating
MD
01/19MARKET SUCCESS : More than 1,000 reference plants worldwide with SEPURAN« membranes for ga..
PU
01/18EVONIK : UBS remains its Buy rating
MD
01/17Evonik pioneers industrial-scale manufacturing of biosurfactants
AQ
01/17Evonik builds world's first industrial-scale production plant for rhamnolipids
AQ
01/17EVONIK INDUSTRIES : Virtual German Corporate Conference (Kepler Cheuvreux)
PU
01/14Evonik plans to build production plant in Slovakia
RE
01/14EVONIK INDUSTRIES : builds world's first industrial-scale production plant for rhamnolipid..
PU
01/13EVONIK INDUSTRIES : develops sustainable amorphous poly-alpha-olefins for the Adhesives In..
PU
01/11EVONIK INDUSTRIES : Virtual German Coporate Conference, NY (Berenberg)
PU
More news
Analyst Recommendations on EVONIK INDUSTRIES AG
More recommendations
Financials
Sales 2021 14 662 M 16 479 M 16 479 M
Net income 2021 803 M 902 M 902 M
Net Debt 2021 2 646 M 2 974 M 2 974 M
P/E ratio 2021 16,9x
Yield 2021 4,02%
Capitalization 13 472 M 15 200 M 15 142 M
EV / Sales 2021 1,10x
EV / Sales 2022 1,03x
Nbr of Employees 32 891
Free-Float 41,1%
Chart EVONIK INDUSTRIES AG
Duration : Period :
Evonik Industries AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EVONIK INDUSTRIES AG
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 28,91 €
Average target price 32,65 €
Spread / Average Target 12,9%
EPS Revisions
Managers and Directors
Christian Kullmann Chairman-Management Board
Ute Wolf Chief Financial Officer
Bernd T÷njes Chairman-Supervisory Board
Andreas Fischer Chief Innovation Officer
Volker Trautz Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
EVONIK INDUSTRIES AG0.49%15 039
BASF SE5.75%67 571
SHIN-ETSU CHEMICAL CO., LTD-8.96%66 122
DUPONT DE NEMOURS, INC.-4.89%39 806
ROYAL DSM N.V.-16.49%31 808
PIDILITE INDUSTRIES LIMITED5.13%17 599